GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8BOW | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with an inhibitor 617 | |
8BON | P10104 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
8BON | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
8BON | 8BON | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
8BOL | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with an inhibitor P18 | |
8BO8 | Q04609 | X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with an inhibitor P17 | |
8BN5 | Q9ULK0 | Crystal structure of the ligand-binding domain (LBD) of human iGluR Delta-1 (GluD1) in complex with GABA | |
8BN2 | Q9ULK0 | Crystal structure of the ligand-binding domain (LBD) of human iGluR Delta-1 (GluD1) in complex with D-Serine | |
8BLW | Q8A7N5 | Vitamin B12 transporter BtuB1 with lipoprotein BtuG1 from B. theta | |
8BLW | Q8A7N4 | Vitamin B12 transporter BtuB1 with lipoprotein BtuG1 from B. theta | |
8BLP | Q13336 | Human Urea Transporter UT-B/UT1 in Complex with Inhibitor UTBinh-14 | |
8BLJ | Q9ULK0 | Crystal structure of the ligand-binding domain (LBD) of human iGluR Delta-1 (GluD1), apo state | |
8BLJ | Q9ULK0-2 | Crystal structure of the ligand-binding domain (LBD) of human iGluR Delta-1 (GluD1), apo state | |
8BLB | P46098 | Human serotonin 5-HT3A receptor in complex with vortioxetine (nanodiscs, ECD, active/distorted conformation) | |
8BLA | P46098 | Human serotonin 5-HT3A receptor in complex with vortioxetine (detergent, ECD only, active/distorted conformation) | |
8BL8 | P46098 | Human serotonin 5-HT3A receptor (apo, active/distorted conformation) | |
8BJZ | 8BJZ | crystal structure of antibody Fab with SiaLac-amidine-Lys | |
8BJO | A0A7I9C8Z1 | Crystal structure of Paradendryphiella salina PL7C alginate lyase mutant Y220F in complex with hexa-mannuronic acid | |
8BHS | P31644 | GABA-A receptor a5 homomer - a5V3 - RO4938581 | |
8BHR | P31644 | GABA-A receptor a5 homomer - a5V3 - RO7015738 | |
8BHQ | P31644 | GABA-A receptor a5 homomer - a5V3 - RO7172670 | |
8BHO | P31644 | GABA-A receptor a5 homomer - a5V3 - L655708 | |
8BHM | P31644 | GABA-A receptor a5 homomer - a5V3 - DMCM | |
8BHK | P31644 | GABA-A receptor a5 homomer - a5V3 - Diazepam | |
8BHI | P31644 | GABA-A receptor a5 homomer - a5V3 - RO5211223 | |
8BHH | A0A1D3S5H0 | The crystal structure of a feruloyl esterase C from Fusarium oxysporum in complex with p-coumaric acid | |
8BHG | P31644 | GABA-A receptor a5 heteromer - a5V2 - Bretazenil | |
8BHG | P18507 | GABA-A receptor a5 heteromer - a5V2 - Bretazenil | |
8BHB | P31644 | GABA-A receptor a5 homomer - a5V3 - RO154513 | |
8BHA | P31644 | GABA-A receptor a5 homomer - a5V3 - Basmisanil - HR | |
8BH5 | 8BH5 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
8BH5 | P0DTC2 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
8BGW | A0A0D6H8R3 | CryoEM structure of quinol-dependent Nitric Oxide Reductase (qNOR) from Alcaligenes xylosoxidans at 2.2 A resolution | |
8BGO | A0A160VQZ8 | N,N-diacetylchitobiose deacetylase from Pyrococcus chitonophagus with substrate N,N-diacetylchitobiose | |
8BGI | P31644 | GABA-A receptor a5 homomer - a5V1 - Flumazenil | |
8BGG | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8BGG | 8BGG | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8BG8 | P0DTC2 | SARS-CoV-2 S protein in complex with pT1696 Fab | |
8BG8 | 8BG8 | SARS-CoV-2 S protein in complex with pT1696 Fab | |
8BG6 | 8BG6 | SARS-CoV-2 S protein in complex with pT1644 Fab | |
8BG6 | P0DTC2 | SARS-CoV-2 S protein in complex with pT1644 Fab | |
8BG5 | 8BG5 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV | |
8BG5 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV | |
8BG4 | 8BG4 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV | |
8BG4 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV | |
8BG3 | 8BG3 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV | |
8BG3 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV | |
8BG2 | 8BG2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV | |
8BG2 | P0DTC2 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV | |
8BG1 | 8BG1 | Crystal structure of the SARS-CoV-2 S RBD in complex with pT1511 scFV |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024